Avian Metapneumorvirus (aMPV)
Vaccine Solutions
Avian Metapneumorvirus (aMPV)
Vaccine Solutions
Elanco partners with HIPRA to provide RESPIVAC® aMPV and HIPRAVIAR®TRT. Together, these vaccines offer reliable prevention options for poultry producers facing respiratory health challenges.
Protect your flock from aMPV
Avian metapneumovirus (aMPV), is a highly contagious pathogen affecting poultry, which can lead to mortality, a decrease in performance and significant economic losses. Elanco partners with HIPRA, a global leader in poultry vaccines, to bring RESPIVAC® aMPV and HIPRAVIAR®TRT to U.S. producers. These complementary vaccines provide flexible options for managing avian metapneumovirus in chickens and turkeys, supporting flock health, protecting performance, and helping producers meet business goals.
Live aMPV Vaccine for Poultry
RESPIVAC® aMPV is a live vaccine from HIPRA to help protect poultry against avian metapneumovirus. RESPIVAC® aMPV supports respiratory health in broilers, breeders, and layers. Administer via coarse spray from day 1, or in drinking water from day 7. Always follow the label.
Key Features
Live aMPV subtype B vaccine
The safety of RESPIVAC® aMPV has been demonstrated during lay
Spray or drinking water administration
RESPIVAC® aMPV
Learn from the Leaders at the Elanco Poultry Hub
Tap into the Elanco Poultry Hub, a library of insights from our team of industry-leading experts. Learn the latest on products, services, trends, best practices and more.
Elanco US Inc. has been issued an import permit for the importation of HIPRAVIAR®TRT and RESPIVAC® aMPV for vaccination of US flocks.
FOR VETERINARY USE ONLY.
HIPRAVIAR®TRT and RESPIVAC® aMPV are trademarks of Laboratorios Hipra, S.A. Elanco and the diagonal bar logo are trademarks of Elanco.
© 2026 Elanco or its affiliates.
